S. B. Hanauer

4.1k citations
46 papers · 3.2k · 2 hit papers · h-index 20

Impact in

  • Genetics top 0.5%
    • Inflammatory Bowel Disease
    • Microscopic Colitis
    • Autoimmune and Inflammatory Disorders

Papers in

    • Inflammatory Bowel Disease 34
    • Chronic Lymphocytic Leukemia Research 6
    • Microscopic Colitis 15

S. B. Hanauer

44 papers receiving 3.1k citations

S. B. Hanauer's Hit Papers

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial 2007 · 804 citations
8040+8+16Years since publication250500750

Peers

S. B. Hanauer
Comparison fields: 5 of 104
  • Genetics 1.9k
  • Epidemiology 995
  • Hematology 327
  • Immunology 563
  • Rheumatology 377
Replace Mark T. Osterman with:
Mark T. Osterman United States
Stephan Targan United States
Ian C. Lawrance Australia
Milan Lukáš Czechia
Lori Y. Kam United States
Ambrogio Orlando Italy
Niels Vande Casteele United States
Mathurin Fuméry France
Stephen J. Bickston United States
Frank Anderson Canada
S. B. Hanauer relative to Mark T. Osterman United States Mark T. Osterman's profile →
Citations per field
00.5×1.5×2.1×
Mark T. Osterman · 1×
Citations per year

Countries citing papers authored by S. B. Hanauer

Since Specialization
Citations

This map shows the geographic impact of S. B. Hanauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. B. Hanauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. B. Hanauer more than expected).

Fields of papers citing papers by S. B. Hanauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. B. Hanauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. B. Hanauer. The network helps show where S. B. Hanauer may publish in the future.

Co-authors

The 25 scholars most cited alongside S. B. Hanauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. B. Hanauer Line = papers co-authored together S. B. Hanauer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Hit paper breakdown →
2007804
2
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Hit paper breakdown →
2001704
3 1999242
4 2002210
5 2001197
6 1999140
7 2010114
8 201393
9
Cyclosporin for severe ulcerative colitis: a user's guide.
199786
10 200381
11 198847
12 200445
13 198144
14 199638
15 201038
16 201136
17 198935
18
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
199335
19 200828
20 201120

About S. B. Hanauer

S. B. Hanauer is a scholar working on Genetics, Epidemiology, Immunology, Genetics and Surgery, having authored 46 papers that have together received 3.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (34 papers), Microscopic Colitis (15 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Gastrointestinal motility and disorders (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Genetics (1.9k citations), Epidemiology (995 citations), Hematology (327 citations), Immunology (563 citations) and Rheumatology (377 citations). S. B. Hanauer has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include William J. Sandborn, Michael Safdi, Seymour Katz, P Pollack, Remo Panaccione, Douglas C. Wolf, P. Rutgeerts, A. R. Zinsmeister, William J. Tremaine and Richard D. Baerg. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, The American Journal of Gastroenterology, Gastroenterology, Inflammatory Bowel Diseases and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact